Paul W. Blavin
Gründer bei Mercy Bioanalytics, Inc.
Profil
Paul W.
Blavin founded Mercy Bioanalytics, Inc. in 2018, where he is working as Vice Chairman from 2023.
Mr. Blavin also founded PWB Value Partners LP.
Mr. Blavin also formerly worked at Blavin & Co., Inc., as Chairman & Chief Executive Officer.
Mr. Blavin received his undergraduate degree from the University of Michigan and Masters Business Admin degree from Harvard Business School.
Aktive Positionen von Paul W. Blavin
Unternehmen | Position | Beginn |
---|---|---|
Mercy Bioanalytics, Inc.
Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology The American company was founded in 2018 by Joseph Sedlak and Paul W. Blavin, and Dawn R. Mattoon has been the CEO of the company since 2022. Mercy Bioanalytics utilizes the patented Mercy Halo liquid biopsy platform to detect stage I cancer, which is most treatable, by analyzing single extracellular vesicles (EVs) that carry unique cancer signatures from their parent cells. The company's initial focus is on the early detection of ovarian and lung cancers, which are difficult to detect and often go undetected until it is too late to cure. The Mercy Halo test makes early-stage cancer detection 100,000 times easier by analyzing EVs found in blood that are specific to their parent cells. | Gründer | 01.01.2018 |
Ehemalige bekannte Positionen von Paul W. Blavin
Unternehmen | Position | Ende |
---|---|---|
PWB Value Partners LP | Gründer | - |
Blavin & Co., Inc.
Blavin & Co., Inc. Investment ManagersFinance Blavin & Co., Inc. is a hedge fund manager located in Scottsdale, Arizona. The firm was founded in 1998 by Paul W. Blavin and Michael Spalter. | Vorsitzender | - |
Ausbildung von Paul W. Blavin
University of Michigan | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Blavin & Co., Inc.
Blavin & Co., Inc. Investment ManagersFinance Blavin & Co., Inc. is a hedge fund manager located in Scottsdale, Arizona. The firm was founded in 1998 by Paul W. Blavin and Michael Spalter. | Finance |
PWB Value Partners LP | |
Mercy Bioanalytics, Inc.
Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology The American company was founded in 2018 by Joseph Sedlak and Paul W. Blavin, and Dawn R. Mattoon has been the CEO of the company since 2022. Mercy Bioanalytics utilizes the patented Mercy Halo liquid biopsy platform to detect stage I cancer, which is most treatable, by analyzing single extracellular vesicles (EVs) that carry unique cancer signatures from their parent cells. The company's initial focus is on the early detection of ovarian and lung cancers, which are difficult to detect and often go undetected until it is too late to cure. The Mercy Halo test makes early-stage cancer detection 100,000 times easier by analyzing EVs found in blood that are specific to their parent cells. | Health Technology |